Olimpia Monti

842 total citations
9 papers, 671 citations indexed

About

Olimpia Monti is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Olimpia Monti has authored 9 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Biotechnology. Recurrent topics in Olimpia Monti's work include Cancer-related Molecular Pathways (8 papers), Cancer Research and Treatments (3 papers) and Cell death mechanisms and regulation (2 papers). Olimpia Monti is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Cancer Research and Treatments (3 papers) and Cell death mechanisms and regulation (2 papers). Olimpia Monti collaborates with scholars based in Italy, Israel and United States. Olimpia Monti's co-authors include Giovanni Blandino, Sabrina Strano, Ada Sacchi, Giulia Fontemaggi, Alessia Baccarini, Massimo Levrero, Giannino Del Sal, Gennaro Citro, Eleonora Lapi and Fiamma Mantovani and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and European Journal of Cancer.

In The Last Decade

Olimpia Monti

9 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olimpia Monti Italy	9	494	358	261	117	92	9	671
Gilda P. Chau United States	12	399 0.8×	392 1.1×	50 0.2×	87 0.7×	123 1.3×	16	553
Eleonora Lapi Spain	11	759 1.5×	396 1.1×	491 1.9×	87 0.7×	109 1.2×	14	1.1k
Edward Tom United States	5	469 0.9×	365 1.0×	52 0.2×	77 0.7×	97 1.1×	5	657
M. Ikeda Japan	4	386 0.8×	374 1.0×	128 0.5×	27 0.2×	54 0.6×	7	559
Andrea Bisso Italy	10	518 1.0×	291 0.8×	78 0.3×	54 0.5×	159 1.7×	17	692
Catherine A. Vaughan United States	14	355 0.7×	330 0.9×	58 0.2×	74 0.6×	121 1.3×	21	552
Jeffrey S. DeFrank United States	7	781 1.6×	536 1.5×	135 0.5×	86 0.7×	155 1.7×	8	887
A. Montagnoli Italy	3	496 1.0×	372 1.0×	138 0.5×	18 0.2×	47 0.5×	7	580
Magdalena M. Maslon United Kingdom	12	537 1.1×	164 0.5×	133 0.5×	24 0.2×	131 1.4×	15	673
Hind Hafsi France	10	385 0.8×	301 0.8×	39 0.1×	67 0.6×	93 1.0×	12	524

Countries citing papers authored by Olimpia Monti

Since Specialization

Citations

This map shows the geographic impact of Olimpia Monti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olimpia Monti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olimpia Monti more than expected).

Fields of papers citing papers by Olimpia Monti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olimpia Monti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olimpia Monti. The network helps show where Olimpia Monti may publish in the future.

Co-authorship network of co-authors of Olimpia Monti

This figure shows the co-authorship network connecting the top 25 collaborators of Olimpia Monti. A scholar is included among the top collaborators of Olimpia Monti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olimpia Monti. Olimpia Monti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Conza, Giusy Di, Marianna Buttarelli, Olimpia Monti, et al.. (2012). IGF-1R/MDM2 Relationship Confers Enhanced Sensitivity to RITA in Ewing Sarcoma Cells. Molecular Cancer Therapeutics. 11(6). 1247–1256. 18 indexed citations

2.

Mancini, Francesca, Giusy Di Conza, Olimpia Monti, et al.. (2010). Puzzling over MDM4–p53 network. The International Journal of Biochemistry & Cell Biology. 42(7). 1080–1083. 24 indexed citations

3.

Agostino, Silvia Di, Giancarlo Cortese, Olimpia Monti, et al.. (2008). The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs. Cell Cycle. 7(21). 3440–3447. 52 indexed citations

4.

Bucci, Barbara, Silvia Misiti, Rodolfo Marchese, et al.. (2007). Fractionated ionizing radiation exposure induces apoptosis through caspase-3 activation and reactive oxygen species generation.. PubMed. 26(6B). 4549–57. 28 indexed citations

5.

Strano, Sabrina, Stefania Dell’Orso, Olimpia Monti, et al.. (2006). Mutant p53 proteins: Between loss and gain of function. Head & Neck. 29(5). 488–496. 37 indexed citations

6.

Strano, Sabrina, Olimpia Monti, Natalia Pediconi, et al.. (2005). The Transcriptional Coactivator Yes-Associated Protein Drives p73 Gene-Target Specificity in Response to DNA Damage. Molecular Cell. 18(4). 447–459. 299 indexed citations

7.

Strano, Sabrina, Olimpia Monti, Natalia Pediconi, et al.. (2005). The Transcriptional Coactivator Yes-Associated Protein Drives p73 Gene-Target Specificity in Response to DNA Damage. Molecular Cell. 19(3). 429–429. 9 indexed citations

8.

Strano, Sabrina, Giulia Fontemaggi, Antonio Costanzo, et al.. (2002). Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities. Journal of Biological Chemistry. 277(21). 18817–18826. 186 indexed citations

9.

Strano, Sabrina, Olimpia Monti, Alessia Baccarini, et al.. (2001). Physical interaction with yes-associated protein enhances p73 transcriptional activity. European Journal of Cancer. 37. S279–S279. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact